MSTN and type 2 diabetes mellitus: But this study also has some strengths, in particular, to our knowledge, this is one of the first studies lasting 12 months that has evaluated the effects of GLP-1RAs on BMD in T2DM patients and it is certainly the first study to have also evaluated BMD by REMS, TBS, adiponectin, and myostatin.